Status:

RECRUITING

Multi-Cancer Detection Observational Cohort Study

Lead Sponsor:

Mayo Clinic

Conditions:

Cancer

Eligibility:

All Genders

21+ years

Brief Summary

This study assesses the incorporation of Multi-Cancer Detection (MCD) testing, designed to detect many types of cancer, into clinical practice to understand both its use and effect in real world pract...

Eligibility Criteria

Inclusion

  • Has Mayo Clinic medical record number
  • Has undergone (within last 6 months) or scheduled to undergo a multi-cancer detection test (MCD) as ordered by provider
  • Able to provide informed consent
  • ≥ 21 years old
  • Ability to provide blood sample

Exclusion

  • Individuals who have situations that would limit compliance with the study requirements
  • Institutionalized (i.e. Federal Medical Prison)
  • Known pregnancy (self-reported)
  • Currently undergoing active cancer treatment other than adjuvant hormone therapy
  • Invasive cancer diagnosis within the last 3 years

Key Trial Info

Start Date :

May 7 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 30 2029

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT06962995

Start Date

May 7 2025

End Date

June 30 2029

Last Update

October 24 2025

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Mayo Clinic in Arizona

Scottsdale, Arizona, United States, 85259

2

Mayo Clinic in Florida

Jacksonville, Florida, United States, 32224-9980

3

Mayo Clinic in Rochester

Rochester, Minnesota, United States, 55905